| 门冬氨酸鸟氨酸治疗显性和轻微型肝性脑病 |
| |
| 引用本文： | 李瑜元. 门冬氨酸鸟氨酸治疗显性和轻微型肝性脑病[J]. 临床肝胆病杂志, 2011, 27(1): 100-102 |
| |
| 作者姓名： | 李瑜元 |
| |
| 作者单位： | 广州市第一人民医院消化内科,广州,510180 |
| |
| 摘 要： | 检索2000年至2010年期间在国内外发表的有关门冬氨酸鸟氨酸治疗显性肝性脑病（HE）和轻微型肝性脑病（MHE）的文献,并进行分析综述。结果显示,门冬氨酸鸟氨酸的治疗机制是直接降低血氨,疗效可靠,无明显不良反应,其对显性HE的疗效已得到公认,对MHE的疗效也在国内外研究中得到初步证实。
|
| 关 键 词： | 肝性脑病 天冬氨酸 鸟氨酸 |
Treatment of hepatic encephalopathy and minimal hepatic encephalopathy with L-ornitine-L-aspartate |
| |
| LI Yu-yuan. Treatment of hepatic encephalopathy and minimal hepatic encephalopathy with L-ornitine-L-aspartate[J]. Chinese Journal of Clinical Hepatology, 2011, 27(1): 100-102 |
| |
| Authors: | LI Yu-yuan |
| |
| Affiliation: | LI Yu-yuan.(Department of Gastroenterology,Guangzhou First Municipal People's Hospital,Guangzhou 510180,China) |
| |
| Abstract: | The domestic and oversea literature on the treatment of hepatic encephalopathy(HE) and minimal hepatic encephalopathy(MHE) with L-ornitine-L-aspartate between 2000 and 2010 were searched and summarized.The results showed that mechanism of the therapy was direct reduction of blood ammonia level.The efficacy and safety of L-ornitine-L-aspartate in the treatment of HE was well recognized and its effect on MHE was primarily accepted. |
| |
| Keywords: | hepatic encephalopathy aspartic acid ornithine |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
